{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:33:56Z","timestamp":1792157636685,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.idc.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T14:30:57Z","timestamp":1334673057000},"page":"359-381","source":"Crossref","is-referenced-by-count":24,"title":["Nematode Infections:"],"prefix":"10.1016","volume":"26","author":[{"given":"Stefanie","family":"Knopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Utzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2012.02.005_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib2","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2012.02.005_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11908-008-0010-2","article-title":"Filarial infections in travelers and immigrants","volume":"10","author":"Klion","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.idc.2012.02.005_bib4","doi-asserted-by":"crossref","first-page":"b1686","DOI":"10.1136\/bmj.b1686","article-title":"The end of lymphatic filariasis?","volume":"338","author":"Bockarie","year":"2009","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2012.02.005_bib5","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.actatropica.2010.08.009","article-title":"Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan\u00ae) monotherapy","volume":"120","author":"Cupp","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.idc.2012.02.005_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pt.2003.09.004","article-title":"Mass drug treatment for lymphatic filariasis and onchocerciasis","volume":"19","author":"Molyneux","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1179\/136485906X112202","article-title":"Towards the elimination of onchocerciasis","volume":"100","author":"Thylefors","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: treatment, control and elimination","volume":"61","author":"Ottesen","year":"2006","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib9","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pntd.0000317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"Ottesen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib10","first-page":"1450","article-title":"Progress toward global eradication of dracunculiasis, January 2010-June 2011","volume":"60","author":"CDC","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2012.02.005_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1179\/136485906X112194","article-title":"Loiasis","volume":"100","author":"Boussinesq","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2012.02.005_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actatropica.2010.01.014","article-title":"Mansonella perstans filariasis in Africa","volume":"120","author":"Simonsen","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.idc.2012.02.005_bib13","series-title":"The global burden of disease: 2004 update","author":"WHO","year":"2008"},{"key":"10.1016\/j.idc.2012.02.005_bib14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2011.03586.x","article-title":"Filariasis in Africa\u2014treatment challenges and prospects","volume":"17","author":"Hoerauf","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2012.02.005_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM198809223191204","article-title":"Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study","volume":"319","author":"Nutman","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2012.02.005_bib16","first-page":"209","article-title":"Imported dracunculiasis\u2014United States, 1995 and 1997","volume":"47","author":"CDC","year":"1998","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2012.02.005_bib17","series-title":"CDC health information for international travel 2012. The Yellow Book","author":"CDC","year":"2011"},{"key":"10.1016\/j.idc.2012.02.005_bib18","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1371\/journal.pntd.0000088","article-title":"Filariasis in travelers presenting to the GeoSentinel Surveillance Network","volume":"1","author":"Lipner","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib19","first-page":"495","article-title":"Dracunculiasis (guinea worm disease)","volume":"170","author":"Greenaway","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.idc.2012.02.005_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.15.2.223-246.2002","article-title":"Dracunculiasis (Guinea worm disease) and the eradication initiative","volume":"15","author":"Cairncross","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2012.02.005_bib21","doi-asserted-by":"crossref","unstructured":"Richards FO, Ruiz-Tiben E, Hopkins DR. Dracunculiasis eradication and the legacy of the smallpox campaign: What\u2019s new and innovative? What\u2019s old and principled? (Presented at the Symposium on Smallpox Eradication: Lessons, Legacies & Innovations). Vaccine 2011, in press; doi: 10.1016\/j.vaccine.2011.07.115.","DOI":"10.1016\/j.vaccine.2011.07.115"},{"key":"10.1016\/j.idc.2012.02.005_bib22","first-page":"1239","article-title":"Progress toward global eradication of dracunculiasis, January 2009-June 2010","volume":"59","author":"CDC","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2012.02.005_bib23","first-page":"189","article-title":"Dracunculiasis eradication\u2014global surveillance summary, 2010","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol\u00a0Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.vetpar.2009.03.026","article-title":"Climate and Dirofilaria infection in Europe","volume":"163","author":"Genchi","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib25","first-page":"231","article-title":"Human dirofilariasis due to Dirofilaria (Nochtiella) repens: an update of world literature from 1995 to 2000","volume":"42","author":"Pampiglione","year":"2000","journal-title":"Parassitologia"},{"key":"10.1016\/j.idc.2012.02.005_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4269\/ajtmh.1998.59.978","article-title":"Immunoepidemiology of Dracunculus medinensis infections I. Antibody responses in relation to infection status","volume":"59","author":"Bloch","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.trstmh.2007.12.003","article-title":"Antibody and cytokine responses in Dracunculus\u00a0medinensis patients at distinct states of infection","volume":"102","author":"Knopp","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4269\/ajtmh.1994.51.797","article-title":"The effect of antibiotic- and hydrocortisone-containing ointments in preventing secondary infections in guinea worm disease","volume":"51","author":"Magnussen","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-308X(05)61007-X","article-title":"Dracunculiasis (Guinea worm disease) eradication","volume":"61","author":"Ruiz-Tiben","year":"2006","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib30","series-title":"Certification of dracunculiasis eradication; criteria, strategies, procedures\u2014a practical guide","author":"WHO","year":"1996"},{"key":"10.1016\/j.idc.2012.02.005_bib31","first-page":"541","article-title":"African Programme for Onchocerciasis Control: meeting of national task forces, September 2011","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib32","series-title":"Final communiqu\u00e9 of the 11th session of the Joint Action Forum (JAF) of APOC","author":"APOC","year":"2005"},{"key":"10.1016\/j.idc.2012.02.005_bib33","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1371\/journal.pmed.0030371","article-title":"River blindness: a success story under threat?","volume":"3","author":"Bas\u00e1\u00f1ez","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2012.02.005_bib34","first-page":"312","article-title":"Report from the 2009 InterAmerican Conference on Onchocerciasis: progress towards eliminating river blindness in the Region of the Americas","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1179\/000349802125000826","article-title":"Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa","volume":"96","author":"Murdoch","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.micinf.2003.11.003","article-title":"Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria","volume":"6","author":"Brattig","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.idc.2012.02.005_bib37","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1126\/science.1068732","article-title":"The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness","volume":"295","author":"Saint Andre","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.idc.2012.02.005_bib38","first-page":"81","article-title":"Monthly report on dracunculiasis cases, January-December 2010","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib39","first-page":"377","article-title":"Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration, 2010","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.trstmh.2008.12.016","article-title":"Filaria control and elimination: diagnostic, monitoring and surveillance needs","volume":"103","author":"Molyneux","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/509325","article-title":"Recent updates on onchocerciasis: diagnosis and treatment","volume":"44","author":"Udall","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib42","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1073\/pnas.0906176106","article-title":"Identifying sub-optimal responses to ivermectin in the treatment of river blindness","volume":"106","author":"Churcher","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2012.02.005_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/QCO.0b013e328315cde7","article-title":"Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis","volume":"21","author":"Hoerauf","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1353\/pbm.2004.0004","article-title":"Profitable gifts: a history of the Merck Mectizan Donation Program and its implications for international health","volume":"47","author":"Collins","year":"2004","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.idc.2012.02.005_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-3156.2004.01209.x","article-title":"Mectizan Donation Program: evaluation of a public-private partnership","volume":"9","author":"Peters","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2012.02.005_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1179\/136485908X337481","article-title":"The Mectizan Donation Program (MDP)","volume":"102","author":"Thylefors","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.1988.39.480","article-title":"Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections","volume":"39","author":"Richard-Lenoble","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-308X(05)61009-3","article-title":"Control of onchocerciasis","volume":"61","author":"Boatin","year":"2006","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/CMR.15.4.595-612.2002","article-title":"History of human parasitology","volume":"15","author":"Cox","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2012.02.005_bib51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-3156.2001.00765.x","article-title":"Lymphatic filariasis: an infection of childhood","volume":"6","author":"Witt","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2012.02.005_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-3024.2005.00792.x","article-title":"Immunomodulation by filarial nematodes","volume":"27","author":"Hoerauf","year":"2005","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.idc.2012.02.005_bib53","first-page":"106","article-title":"Filariasis: diagnosis, treatment and prevention","volume":"79","author":"Palumbo","year":"2008","journal-title":"Acta Biomed"},{"key":"10.1016\/j.idc.2012.02.005_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14656566.6.2.179","article-title":"Treatment strategies underpinning the global programme to eliminate lymphatic filariasis","volume":"6","author":"Gyapong","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.idc.2012.02.005_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1179\/000349804225021451","article-title":"The efficacies of affected-limb care with penicillin diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of acute adenolymphangitis during bancroftian filariasis","volume":"98","author":"Joseph","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib56","first-page":"581","article-title":"Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pt.2006.12.001","article-title":"Diagnostic tools for filariasis elimination programs","volume":"23","author":"Weil","year":"2007","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","article-title":"The ICT Filariasis Test: a rapid-format antigen test for diagnosis of bancroftian filariasis","volume":"13","author":"Weil","year":"1997","journal-title":"Parasitol Today"},{"key":"10.1016\/j.idc.2012.02.005_bib59","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0035-9203(97)90205-4","article-title":"A\u00a0polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens","volume":"91","author":"Ramzy","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1179\/000349802125002356","article-title":"Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis","volume":"96","author":"Williams","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4269\/ajtmh.2009.80.769","article-title":"Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa","volume":"80","author":"Mladonicky","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0001-706X(00)00159-5","article-title":"Encephalopathy following Loa loa treatment with albendazole","volume":"78","author":"Blum","year":"2001","journal-title":"Acta Trop"},{"key":"10.1016\/j.idc.2012.02.005_bib63","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(05)66591-9","article-title":"Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial","volume":"365","author":"Taylor","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib64","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/586753","article-title":"Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment","volume":"46","author":"Supali","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib65","series-title":"Fiftieth World Health Assembly. Elimination of lymphatic filariasis as a public health problem. WHA50.29","author":"WHO","year":"1997"},{"key":"10.1016\/j.idc.2012.02.005_bib66","series-title":"Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis","author":"WHO","year":"2010"},{"key":"10.1016\/j.idc.2012.02.005_bib67","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pt.2006.05.010","article-title":"Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme","volume":"22","author":"Mohammed","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib68","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-3156.2000.00661.x","article-title":"Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil","volume":"5","author":"Schlemper","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2012.02.005_bib69","first-page":"359","article-title":"Lymphatic filariasis in India: problems, challenges and new initiatives","volume":"62","author":"Agrawal","year":"2006","journal-title":"MJAFI"},{"key":"10.1016\/j.idc.2012.02.005_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2883-5-5","article-title":"Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling","volume":"5","author":"Stolk","year":"2006","journal-title":"Filaria J"},{"key":"10.1016\/j.idc.2012.02.005_bib71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"The global programme to eliminate lymphatic filariasis","volume":"5","author":"Ottesen","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2012.02.005_bib72","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(06)68426-2","article-title":"Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment","volume":"367","author":"Ramzy","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib73","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(06)68404-3","article-title":"Elimination of transmission of lymphatic filariasis in Egypt","volume":"367","author":"Molyneux","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib74","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3201\/eid1304.061063","article-title":"Endpoints for lymphatic filariasis programs","volume":"13","author":"Grady","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/136485905X29701","article-title":"Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis","volume":"99","author":"Ramaiah","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib76","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(06)69100-9","article-title":"Elimination of lymphatic filariasis","volume":"368","author":"Michael","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2012.02.005_bib77","series-title":"Report of a WHO informal consultation on epidemiologic approaches to lymphatic filariasis elimination: initial assessment, monitoring and certification","author":"WHO","year":"1998"},{"key":"10.1016\/j.idc.2012.02.005_bib78","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pt.2006.03.005","article-title":"Mathematical models and lymphatic filariasis control: endpoints and optimal interventions","volume":"22","author":"Michael","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2012.02.005_bib79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4419-6064-1_11","article-title":"Transmission models and management of lymphatic filariasis elimination","volume":"673","author":"Michael","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.idc.2012.02.005_bib80","first-page":"121","article-title":"WHO position statement on integrated vector management to control malaria and lymphatic filariasis","volume":"13","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.idc.2012.02.005_bib81","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.trstmh.2008.03.022","article-title":"Loiasis: African eye worm","volume":"102","author":"Padgett","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0035-9203(03)90114-3","article-title":"Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon","volume":"97","author":"Wanji","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib83","series-title":"Parasitology for medical and clinical laboratory professionals","author":"Ridley","year":"2011"},{"key":"10.1016\/j.idc.2012.02.005_bib84","first-page":"45","article-title":"Subconjunctival Loa loa worm: case report","volume":"283","author":"Carbonez","year":"2002","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.idc.2012.02.005_bib85","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4269\/ajtmh.1991.44.684","article-title":"Five cases of encephalitis during treatment of loiasis with diethylcarbamazine","volume":"44","author":"Carme","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib86","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/168.1.202","article-title":"Albendazole in human loiasis: results of a double-blind, placebo-controlled trial","volume":"168","author":"Klion","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4269\/ajtmh.2004.71.5_suppl.0700007","article-title":"Essential tools\u2014drugs and clinical drug trials","volume":"71","author":"Bradley","year":"2004","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.idc.2012.02.005_bib88","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1371\/journal.pntd.0001210","article-title":"The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)","volume":"5","author":"Zour\u00e9","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2012.02.005_bib89","series-title":"Guidelines for rapid assessment of Loa loa","author":"WHO\/TDR","year":"2002"},{"key":"10.1016\/j.idc.2012.02.005_bib90","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa0900863","article-title":"A\u00a0randomized trial of doxycycline for Mansonella perstans infection","volume":"361","author":"Coulibaly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2012.02.005_bib91","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.trstmh.2005.07.009","article-title":"Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis","volume":"100","author":"Bregani","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.trstmh.2008.10.038","article-title":"A\u00a0randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda","volume":"103","author":"Asio","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2012.02.005_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.socscimed.2008.09.040","article-title":"Health-related stigma among women with lymphatic filariasis from the Dominican Republic and Ghana","volume":"68","author":"Person","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.idc.2012.02.005_bib94","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1371\/journal.pntd.0000414","article-title":"Marriage, sex, and hydrocele: an ethnographic study on the effect of filarial hydrocele on conjugal life and marriageability from Orissa, India","volume":"3","author":"Babu","year":"2009","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T02:23:55Z","timestamp":1551925435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552012000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0891552012000062"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2012.02.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}